earticle

영어

Although Parties, directly involved, had made contracts for a technology transfer or a patent license for the purpose of research and development in the past, the new form of contract, a material transfer agreement, emerged in the late 20th century. Especially, as a biotechnology was developed and patent for life was allowed, the biological material transfer agreement became increased rapidly. The biological material transfer agreement could be made variously d epending on the form of transfer, sort of material, parties, directly involv ed, and whether they could be paid or not. Securing a right to material i s a key point for providers and gaining a right to product of work is mai n point for receivers. So the material transfer agreement should correctl y reflect the intention of providers who have expertise on materials and balance the claims and obligations of providers and receivers. Also it sh ould deal with problems of intellectual property rights to materials and p roducts of work. Uniform Biological Material Transfer Agreement(UBMTA) of National I nstitutes of Health(NIH) is used as a global standard. But UBMTA only r egulates relationships between public organizations and non-profit organi zations, so the study should be done to prepare a standard which rules r elationships between profit-making organizations, public organizations and profit-making organizations, and public organizations and non-profit orga nizations. Also the material transfer agreement, made according to the un ique characteristics of materials, should be developed by grasping charac teristics of each material. Furthermore, Access and Benefit Sharing(ABS) agreement could be mi xed up with the material transfer agreement because it also deals with li fe like genetic resources and it uses a name of the material transfer agr eement. So, the study which compares and analyzes the material transfer agreement and ABS agreement should be done.